Compare J.B.Chemicals with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs DR. REDDYS LAB - Comparison Results

J.B.CHEMICALS     Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS DR. REDDYS LAB J.B.CHEMICALS/
DR. REDDYS LAB
 
P/E (TTM) x 16.8 22.3 75.3% View Chart
P/BV x 2.3 3.3 69.5% View Chart
Dividend Yield % 0.5 0.7 71.7%  

Financials

 J.B.CHEMICALS   DR. REDDYS LAB
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-18
DR. REDDYS LAB
Mar-19
J.B.CHEMICALS/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs3632,875 12.6%   
Low Rs2551,888 13.5%   
Sales per share (Unadj.) Rs169.1930.2 18.2%  
Earnings per share (Unadj.) Rs16.6117.4 14.1%  
Cash flow per share (Unadj.) Rs23.4185.8 12.6%  
Dividends per share (Unadj.) Rs2.0020.00 10.0%  
Dividend yield (eoy) %0.60.8 77.1%  
Book value per share (Unadj.) Rs172.5844.4 20.4%  
Shares outstanding (eoy) m83.57166.07 50.3%   
Bonus/Rights/Conversions BBESOP-  
Price / Sales ratio x1.82.6 71.4%   
Avg P/E ratio x18.620.3 91.8%  
P/CF ratio (eoy) x13.212.8 102.9%  
Price / Book Value ratio x1.82.8 63.5%  
Dividend payout %12.017.0 70.7%   
Avg Mkt Cap Rs m25,827395,496 6.5%   
No. of employees `0003.822.0 17.2%   
Total wages/salary Rs m2,51133,562 7.5%   
Avg. sales/employee Rs Th3,747.47,032.8 53.3%   
Avg. wages/employee Rs Th665.71,527.9 43.6%   
Avg. net profit/employee Rs Th367.8887.7 41.4%   
INCOME DATA
Net Sales Rs m14,135154,482 9.1%  
Other income Rs m3663,375 10.8%   
Total revenues Rs m14,501157,857 9.2%   
Gross profit Rs m2,17831,782 6.9%  
Depreciation Rs m57011,348 5.0%   
Interest Rs m35889 3.9%   
Profit before tax Rs m1,94022,920 8.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m0438 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5523,858 14.3%   
Profit after tax Rs m1,38719,500 7.1%  
Gross profit margin %15.420.6 74.9%  
Effective tax rate %28.516.8 169.2%   
Net profit margin %9.812.6 77.7%  
BALANCE SHEET DATA
Current assets Rs m10,470111,101 9.4%   
Current liabilities Rs m2,74958,973 4.7%   
Net working cap to sales %54.633.7 161.9%  
Current ratio x3.81.9 202.2%  
Inventory Days Days5579 69.6%  
Debtors Days Days7894 82.4%  
Net fixed assets Rs m5,811101,245 5.7%   
Share capital Rs m167830 20.1%   
"Free" reserves Rs m14,248139,406 10.2%   
Net worth Rs m14,416140,236 10.3%   
Long term debt Rs m022,000 0.0%   
Total assets Rs m17,649224,656 7.9%  
Interest coverage x56.626.8 211.2%   
Debt to equity ratio x00.2 0.0%  
Sales to assets ratio x0.80.7 116.5%   
Return on assets %8.19.1 88.8%  
Return on equity %9.613.9 69.2%  
Return on capital %13.714.9 91.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m6,16488,673 7.0%   
Fx outflow Rs m1,33419,104 7.0%   
Net fx Rs m4,82969,569 6.9%   
CASH FLOW
From Operations Rs m1,23128,704 4.3%  
From Investments Rs m-208-7,727 2.7%  
From Financial Activity Rs m-595-21,326 2.8%  
Net Cashflow Rs m427-314 -136.0%  

Share Holding

Indian Promoters % 55.4 25.5 217.3%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 5.4 62.8%  
FIIs % 3.9 35.3 11.0%  
ADR/GDR % 0.0 18.5 -  
Free float % 37.0 15.3 241.8%  
Shareholders   30,437 75,885 40.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   SANOFI INDIA  ABBOTT INDIA  PLETHICO PHARMA  CIPLA  TORRENT PHARMA  

Compare J.B.CHEMICALS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Jumps 1,921 Points, FM's Tax Relief, and Top Cues in Focus Today(Pre-Open)

Share markets in India jumped sharply on Friday after Finance Minister Nirmala Sitharaman announced a slew of measures in her media briefing ahead of the GST Council meet.

Related Views on News

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

DR. REDDYS LAB Announces Quarterly Results (1QFY19); Net Profit Up 614.9% (Quarterly Result Update)

Jul 27, 2018 | Updated on Jul 27, 2018

For the quarter ended June 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 614.9% YoY). Sales on the other hand came in at Rs 37 bn (up 12.1% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

My 7 Stocks to Buy Are Companies Which Will Be a Big Part of New India(The 5 Minute Wrapup)

Sep 19, 2019

The India we knew is changing. Here's how you can benefit from this change.

Did the Tax Bonanza Really Deserve a 2,000-point Gain on the Sensex?(Profit Hunter)

Sep 20, 2019

Are investors overdoing their euphoria post the corporate tax cut bonanza?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Sep 20, 2019 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS - WYETH LTD COMPARISON

COMPARE J.B.CHEMICALS WITH

MARKET STATS